It's a bit confusing because they seem to use FY in some cases and CY in others.
But I agree, looks like the next human trial - the bridging safety study in healthy patients - is expected mid-2023.
Seems like a long wait - another 2 years before they even start dosing humans again. And more like 3 years until we see any efficacy data in human IPF.
Let's hope their to-be-announced pipeline products are potential blockbusters and have trials all set to go.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $5.6K | 2.8M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 23616803 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 9545560 | 17 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |